39,616 Results

CHMP recommends Baqsimi, the first treatment for severe hypoglycaemia administered without an injection to patients with diabetes aged four years and older.- Eli Lilly

 Added ago

EMA’s human medicines committee (CHMP) has recommended granting a marketing authorisation in the European Union for Baqsimi (glucagon), from Eli...

CHMP recommends approval of Kalydeco in cystic fibrosis CFTR gene mutation.- Vertex Pharma

 Added 15 hours ago

Vertex Pharmaceuticals (Europe) Limited announces that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted...

Evenity receives positive CHMP opinion for treatment of severe osteoporosis in postmenopausal women at high risk of fracture. Amgen + UCB

 Added 15 hours ago

Amgen and UCB announced that following a re-examination procedure, the Committee for Medicinal Products for Human Use (CHMP) of the...

Phase III VOYAGE 1 study of Tremfya shows efficacy in plaque psoriasis.- Janssen

 Added 15 hours ago

The Janssen Pharmaceutical Companies of Johnson & Johnson announced new long-term data from the open-label period of the Phase III...

CHMP recommends approval of Keytruda in head and neck squamous cell carcinoma.- Merck Inc.

 Added 15 hours ago

Merck announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has adopted a...

CHMP recommends approval of Darzalex + lenalidomide and dexamethasone in multiple myeloma.- Genmab

 Added 15 hours ago

Genmab announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued...

Submission to EMA for Nuzyra in ABSSSI and CABP withdrawn.- Paratek Pharma

 Added 15 hours ago

Paratek Pharmaceuticals announced that the company has withdrawn its submission to the European Medicines Agency (EMA) of the Marketing Authorization...

CHMP recommends approval of Tavalisse in chronic immune thrombocytopenia.- Rigel Pharma

 Added 15 hours ago

Rigel Pharmaceuticals announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA), has...

CHMP does not recommend approval of quizartinib for use in acute myeloid leukemia.- Daiichi Sankyo

 Added 15 hours ago

Daiichi Sankyo announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted...

Herzuma and Truxima biosimilars to be distributed in Australia by Celltrion and to hospitals by Juno Pharmaceuticals.

 Added 15 hours ago

Celltrion Healthcare (Celltrion) has entered into a partnership with Juno Pharmaceuticals (Juno) ( not to be confused with Juno Therapeutics)...

Load more